Systane Contacts

Quick links to important sections

Systane Contacts

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Systane Contacts

Quick Facts

Property Description
Active Ingredients Polyethylene Glycol (PEG 400), Propylene Glycol (PG)
Form Sterile Ophthalmic Solution (Eye Drops)
Pharmacological Class Ophthalmic Demulcent / Lubricant
Common Use Rewetting and lubricating soft and RGP contact lenses
Origin Synthetic Polyols

What is Systane Contacts and its Therapeutic Role?

Systane Contacts is a specialized, commercially available ophthalmic solution formulated as a rewetting agent for use with both soft (hydrophilic) and rigid gas permeable (RGP) contact lenses. The product’s therapeutic role is to offer rapid, temporary relief from minor irritation, dryness, and common discomfort associated with extended or challenging contact lens wear.

The product is classified as an Ophthalmic Demulcent, a category of ingredients recognized for their capacity to lubricate and protect the eye's mucous membranes. This classification reflects its role in providing surface protection. It is intended for topical application directly onto the eyes while the lenses are worn.

Formulation and Composition

Systane Contacts features a combination of the synthetic polyols polyethylene glycol 400 and propylene glycol as its primary active ingredients. A distinctive characteristic of this formulation is its high-molecular-weight polymer blend, which is designed to integrate seamlessly with the natural tear film. This ensures the product helps to provide a durable moisture layer on the lens surface.

Furthermore, the solution is engineered as a neutral, buffered environment that ensures high biocompatibility. This specialized buffering system helps maintain the correct pH balance, making it a suitable choice for sensitive eyes and maximizing patient comfort.

Who is Systane Contacts Intended For?

The product is specifically positioned for contact lens wearers who need to manage lens dryness that may result from environmental challenges, such as prolonged screen use or exposure to dry air. Its general purpose is purely supplemental, focusing on maintaining lens hydration and surface comfort throughout the day. It is an Over-The-Counter (OTC) product.

Regulatory References

  1. NIH DailyMed for Systane-related products

What side effects are possible with Systane Contacts?

Possible Side Effects and Safety Information

The safety profile for Systane Contacts, an ophthalmic solution containing Polyethylene Glycol and Propylene Glycol, is primarily characterized by local ocular adverse reactions as documented in government regulatory labeling. The system-organ-class affected is exclusively the Eye/Ocular System.

Officially Documented Ocular Adverse Reactions

The regulatory labeling identifies specific adverse effects that may occur, though official frequency classifications (such as common or rare) are not typically defined for this over-the-counter product class. Potential adverse effects, which are considered clinically significant if persistent, include:

Adverse Reaction Type Characteristic Regulatory Basis
Adverse Reactions Eye pain Defined as symptoms necessitating professional consultation
Changes in vision Defined as symptoms necessitating professional consultation
Continued redness or irritation Defined as symptoms necessitating professional consultation

Regulatory Safety Considerations

The safety profile includes specific constraints and cautionary notes defined by regulatory authorities. The primary safety restriction is a contraindication against use in individuals with a known hypersensitivity to any ingredient in the product. The label also establishes a duration-triggered safety threshold: if the condition worsens or persists for more than 72 hours, professional consultation is warranted.

Specific safety guidance is included for certain groups. Regulatory text advises that pregnant or breast-feeding individuals consult a health professional prior to using the product. These classifications reflect how government regulatory documents organize and communicate the medicine's safety profile, focusing on documented adverse events and key usage constraints.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for this ophthalmic demulcent solution, which contains polyethylene glycol and propylene glycol, provides guidance strictly focused on the risks associated with accidental ingestion. Because the product is intended for topical ocular use, swallowing the solution represents the documented overdose circumstance. Official labeling classifies this product as potentially harmful if swallowed.

Documented Manifestations and Emergency Actions

The regulatory profile outlines specific, severe clinical manifestations that serve as clear triggers for seeking immediate medical attention following ingestion.

Element Regulatory Guidance Summary
Overdose Cause Accidental ingestion of the ophthalmic solution.
Severe Symptoms Symptoms considered severe include passing out (loss of consciousness) or experiencing trouble breathing (respiratory distress).
Immediate Action Contact a Poison Control Center right away if the solution is swallowed.
Urgent Medical Help Call emergency services (911) immediately if, following ingestion, passing out or trouble breathing occurs.

Management of an overdose involves standard symptomatic and supportive treatment, which is directed by emergency medical professionals. No specific antidote or population-specific considerations regarding overdose severity are documented in the official regulatory labeling for this Over-the-Counter product class.

Therapeutic Uses of Systane Contacts

What Systane Contacts Treats: Main Uses and Benefits

Relief from Contact Lens-Related Discomfort

The rewetting drops are commonly used to help with episodic or fluctuating manifestations and dryness that is specifically associated with the wear of soft (hydrophilic) and rigid gas permeable (RGP) contact lenses. The product is applied across domains where additional symptomatic support is needed, helping address symptoms related to physical discomfort that may become more disruptive during flare-ups. The product plays a role in managing the feeling of dryness.


Sustaining Functional Stability

The solution is applied in clinical settings that involve acute or unstable symptom patterns, often used during phases when symptoms become more noticeable due to environmental or sustained functional stress. This is relevant when symptoms become temporarily overwhelming and may assist with maintaining functional stability, providing supportive relief when symptoms interfere with routine activities. The primary therapeutic domains include managing symptoms related to irritative states, functional stability, and relief of discomfort.


“The primary goal is to provide supportive relief, helping patients cope more steadily with symptom fluctuations that affect comfort during lens use.”


Quick Fact: Relief for Symptoms Related to Irritative States

Symptom Targeted Context of Use Benefit Provided
Symptoms related to physical discomfort Applied in clinical settings that involve acute or unstable symptom patterns Contributes to improved comfort during periods of heightened symptoms

Regulatory References

  1. National Institutes of Health’s DailyMed database

Eligibility and Restrictions for Use

The eligibility for Systane Contacts Lubricant Eye Drops is governed by its classification as an Over-The-Counter (OTC) topical ophthalmic solution, with usage defined by specific population allowances and a single regulatory prohibition.

Eligibility Scope

Classification Rule (Official Regulatory Status)
Populations Allowed Individuals wearing soft (hydrophilic), rigid gas permeable (RGP), and hard contact lenses. Use is established for the general adult population.
Populations Contraindicated Individuals with a known hypersensitivity or allergy to any ingredient in the product. The official label specifies, “Do not use… if you are sensitive to any ingredient in this product.”

Age and Condition-Related Eligibility

  • Age-Related Rules: Use is permitted for adults and older adults without specific age-related restrictions. The label advises that the product must be “kept out of reach of children,” which typically suggests consultation with a healthcare professional for pediatric use.
  • Systemic Conditions: No restrictions related to hepatic or renal impairment are documented in the official labeling, consistent with the minimal systemic absorption of a topical ophthalmic product.
  • Pregnancy and Lactation: The product label generally advises that the user should “Ask a healthcare professional” before use if pregnant or breastfeeding.

The official regulatory documents define eligibility by this product's topical nature and specific indication, permitting use only in the population of contact lens wearers, with an absolute prohibition based on ingredient allergy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope and Classification

The official regulatory profile for ophthalmic demulcent solutions containing Polyethylene Glycol and Propylene Glycol is highly constrained due to the product's topical administration and negligible systemic absorption. Consequently, regulatory documents do not document systemic pharmacokinetic interactions, such as those involving CYP enzymes or drug transporters, nor do they list contraindicated drug combinations. There are no documented interactions with food, alcohol, or herbal products.

Interaction Entity Category Documented Interaction Statement
Timing / Separation Requirements Must be administered separately from other ophthalmic products
Interacting Product Category Other topical ophthalmic solutions or ointments
Systemic Interactions None documented (e.g., metabolic, pharmacodynamic)

Administration-Timing Restriction

Interactions with this ophthalmic solution are restricted to a local physical interference when co-administered with other eye medications. Official regulatory labeling stipulates a mandatory timing rule to prevent the dilution or wash-out of a co-administered product's active ingredients. This timing rule requires that the lubricating solution must be administered at least 5 minutes apart from any other topical ophthalmic drug. This single, localized restriction defines the entirety of the documented interaction profile for the product.

Mechanism of Action

The mechanism of action involves the localized delivery of hydrophilic demulcents and a polymeric gelling agent to the ocular surface and contact lens interface. Upon instillation, the formulation is exposed to the higher physiological pH and presence of divalent ions (e.g., calcium, zinc) in the tear film. This change in the microenvironment facilitates the reversible cross-linking interaction between the hydroxypropyl-guar (HP-guar) polymer and borate ions.

This chemical modification drives a transition from a low-viscosity liquid to a viscoelastic gel-matrix on the corneal and contact lens surface. The resulting polymer matrix exhibits shear-thinning properties, allowing for non-disruptive distribution across the ocular surface during blinking, and muco-adhesive properties, promoting selective accumulation and prolonged retention of the polyethylene glycol and propylene glycol demulcents. This sustained muco-adhesion functionally stabilizes the aqueous-mucin layer of the tear film, decreasing the rate of tear film break-up and reducing water loss from the ocular epithelium. The system-level physiological consequence is the localized modulation of tear film stability and the functional preservation of epithelial hydration.

Dosage and Administration Information

How to Use Systane Contacts

This section outlines the usage instructions for the Systane Contacts ophthalmic solution, detailing the administration protocol.


Administration Protocol

The product is classified for topical ophthalmic instillation, meaning it is applied externally directly into the eye. The administration is governed by a standard volume, where the dose is defined as one or two drops instilled into the eye designated for treatment.

Unlike fixed-schedule medications, the dosing pattern is designated as as needed throughout the day. This dictates that the solution is intended for intermittent use to provide temporary support, rather than being part of a fixed, predetermined regimen.


Usage Context and Procedural Rules

Special Procedural Condition: The solution is formulated specifically for use while wearing contact lenses. This is the defining condition for administration, confirming its intended role as a rewetting and lubricating agent for both soft (hydrophilic) and Rigid Gas Permeable (RGP) lenses.

Handling: To maintain the sterility of the solution, the instructions require the user to avoid contaminating the dropper tip by preventing contact with the eye, fingers, or any other surface during the instillation process.

Overall Use Protocol: This usage framework establishes a topical, intermittent-use procedure. The administration of one or two drops ensures the delivery of the defined volume, while the 'as needed' frequency means the application is driven by temporary discomfort, not a continuous schedule.

Recent Clinical Evidence

Evidence for Relieving Contact Lens Dryness and Discomfort

Studies have explored how Systane Contacts relates to outcomes related to physical discomfort experienced by contact lens wearers, specifically focusing on feelings of dryness and irritation. Research examined these patient-reported outcomes describing perceived discomfort in people who experience symptoms of dryness while wearing their lenses. Findings from these studies generally describe patterns of change in the intensity of dryness symptoms measured during the study period.

The types of studies applied in studies examining patient-reported experiences often involve tracking how participants rate their discomfort levels over defined time intervals. These studies contribute to the broader evidence landscape by helping contextualize how patients reported their experience with conditions characterized by fluctuating or episodic manifestations. However, results apply only to the populations studied, and the consistency of these findings across all types of contact lens wearers is still being explored.


Evidence for Improving Overall Contact Lens Wear Comfort

Research was studied for its relationship to broader comfort measures that outcomes reflect daily functioning or activity level, such as the wear time and ease of wearing soft contact lenses. Studies explored how the use of Systane Contacts related to general feelings of lens wear comfort, particularly in conditions where symptoms may vary in intensity throughout the day. Data show patterns related to patient-reported outcomes describing perceived comfort and wear time was observed in some studies.

These results are primarily evidence derived from settings with varying symptom burdens, meaning participants included those with varying degrees of mild to moderate discomfort. While the research provides insight into short-term changes in comfort, comparative evidence is lacking. Follow-up durations were limited in many of these investigations, meaning that the full picture of patterns of change in comfort are still being investigated.


What is Still Uncertain About Systane Contacts

Research contributes to the broader evidence landscape, but there are still areas where more information is needed. While change in patient-reported outcomes describing perceived comfort was associated with the use of the product in many studies, findings were mixed on certain measures of physical discomfort. This section synthesizes the areas where evidence is limited and where future research may clarify current findings.

For example, comparative evidence is lacking across all types of outcomes describing episodic or acute changes. Also, the results apply only to the populations studied, and research does not determine whether an individual will respond similarly outside the specific conditions under which the studies were conducted. Evidence highlights what is known—and what is still uncertain—and ongoing research is necessary to fully address these gaps.

Frequently Asked Questions (FAQ)

Common questions about Systane Contacts (FAQ)


Q: How quickly should I expect to feel relief after using Systane Contacts?

Official product information describes this solution as being intended for the temporary relief of minor irritation and discomfort caused by contact lens wear. It is formulated to provide moisture and lubrication to the lens surface.


Q: Can using Systane Contacts too often be harmful?

Regulatory labeling advises that if your eye condition worsens or persists for more than 72 hours after beginning use, you should stop using the product and consult a healthcare professional. This advisory regarding when to stop use is defined in the official warnings section.


Q: Is Systane Contacts safe for use by children or teenagers?

The product label includes the standard advisory to keep it out of reach of children. Official documentation advises consultation with a healthcare professional regarding use of the product for children or adolescents.


Q: What is the difference between rewetting drops and lubricating drops like Systane Contacts?

The product is officially classified as an Ophthalmic Demulcent, a category of ingredients recognized by regulatory bodies for their capacity to both lubricate and protect the eye's mucous membranes. This classification indicates it supports the function of both rewetting and lubricating the ocular surface.


Q: Does Systane Contacts help with blurry vision caused by dry contact lenses?

Temporary changes in vision, which may include blurring, can occur when the product is first used. Official regulatory labeling indicates that if persistent changes in vision are experienced, or if the condition lasts longer than 72 hours, stopping use and consulting a professional is warranted.


Q: What happens if I use Systane Contacts and I'm not wearing contacts?

This product is specifically indicated for use with soft, rigid gas permeable (RGP), and hard contact lenses. While regulatory labeling does not document specific issues from using the drops when lenses are not worn, the primary intended therapeutic role focuses on the contact lens interface.


Q: Is it normal to feel a slight stinging when first using Systane Contacts?

Official product information may note that minor symptoms such as temporary burning or stinging can occur when the product is initially used. If such sensations are severe or persist, official regulatory guidance indicates that stopping use and seeking professional advice is appropriate.


Q: Is Systane Contacts available without a prescription?

Yes, this product is classified as an Over-The-Counter (OTC) drug product by regulatory bodies, meaning it is available for purchase without requiring a prescription.


Q: What kind of research has been done on the safety of Systane Contacts?

The product's classification as an Ophthalmic Demulcent is based on the regulatory recognition of the active ingredients—Polyethylene Glycol and Propylene Glycol—for their established roles in providing surface protection and lubrication to the eye.


Q: Is Systane Contacts approved for overnight-wear contact lenses?

The official labeling defines the product's indication for use with both daily and extended-wear soft and rigid gas permeable lenses, under the guidance of an eye care practitioner.


Q: Can I use Systane Contacts if I have sensitive skin around my eyes?

Regulatory information focuses primarily on ocular adverse reactions (adverse effects that occur in the eye itself), such as pain or irritation, and does not document specific side effects or warnings related to sensitivity of the surrounding skin.


Q: What should I do if my vision temporarily blurs after using Systane Contacts?

Vision may be temporarily blurred when the product is first administered. However, regulatory labeling advises that if changes in vision occur or the condition persists for more than 72 hours, the user should discontinue use and consult a healthcare professional.


Q: Are there any warnings about driving or operating machinery after using Systane Contacts?

Regulatory warnings state that your vision may be temporarily blurred when the product is first used. Official guidance indicates this temporary effect should be considered before engaging in activities like driving or operating machinery.


Q: Is it true that Systane Contacts is a high-viscosity drop?

Regulatory documentation describes the solution as one that is designed to form a viscoelastic gel-matrix on the ocular surface upon contact with the tear film. This gel-matrix is a state of consistency that is higher than a standard liquid drop.


Q: Why is it important to use contact-specific drops like Systane Contacts?

Official labeling confirms that this product is specifically formulated and indicated for use while wearing contact lenses. This confirms that the solution is designed to be compatible with contact lens materials.


Q: Is Systane Contacts suitable for daily disposable contact lenses?

Yes, the official labeling confirms the product is indicated for use with daily and extended-wear soft and rigid gas permeable contact lenses.


Q: Can I use Systane Contacts with medicated eye solutions?

Yes, but regulatory labeling stipulates a mandatory timing rule to avoid physical interference. This rule requires that this product must be administered at least 5 minutes apart from any other topical ophthalmic drug or solution.


Q: Does Systane Contacts have a known potential for allergic reactions?

Yes. The regulatory labeling contains a contraindication stating that the product should not be used by individuals with a known hypersensitivity to any ingredient in the product. This confirms the potential for ingredient-specific allergic reactions.


Q: Can I use Systane Contacts if I have a history of dry eye disease?

The product's intended use, as defined in official documentation, is the temporary relief of burning and irritation due to the dryness of the eye, which may be related to symptoms experienced in dry eye conditions.


Q: How does the formulation of Systane Contacts differ from regular artificial tears?

The formulation uses Polyethylene Glycol and Propylene Glycol and is designed to interact with the tear film. Upon instillation, it forms a viscoelastic gel-matrix on the ocular surface, which provides a lubricating layer.


Q: What is the regulatory status of Systane Contacts (e.g., medical device or drug)?

According to official documentation, the product is classified as a Human Over-The-Counter (OTC) Drug Product. Its pharmacological class is designated as an Ophthalmic Demulcent.


Q: How does the use of Systane Contacts relate to overall contact lens hygiene?

Official instructions indicate that, to maintain sterility, care should be taken to avoid contaminating the dropper tip by preventing contact with any surface, including the eye or fingers.


Q: How does Systane Contacts interact with different contact lens solutions?

The regulatory interaction profile is restricted to co-administered topical ophthalmic solutions or ointments (which include medicated solutions). It requires a minimum 5-minute separation to prevent physical interference.

How should Systane Contacts be stored and disposed of?

How to Store and Dispose of Systane Lubricant Eye Drops

Official regulatory documents define specific requirements for storing, handling, and disposing of this ophthalmic product to maintain sterility and stability.

Storage and Handling

Condition Requirement (Based on Official Label)
Temperature Store at room temperature (e.g., 15°C to 30°C). Do not freeze.
Asepsis To prevent contamination, do not touch the container tip to any surface. Replace the cap immediately after use.
Child Safety Keep out of reach of children. Seek emergency medical help if swallowed.

Stability and Disposal

Condition Requirement (Based on Official Label)
Stability Single-use vials must be discarded immediately after one use. Multi-dose bottles must be discarded after the officially specified period (e.g., 3 months) from opening.
Disposal Properly discard expired or unused product according to local guidelines. Do not flush down the toilet or pour into a drain unless specific regulatory instructions advise otherwise.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Systane Contacts found in:

A-Z Index: